ClinVar Miner

Submissions for variant NM_015335.4(MED13L):c.5175G>T (p.Gln1725His) (rs1555243051)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000522127 SCV000619532 likely pathogenic not provided 2017-08-01 criteria provided, single submitter clinical testing The c.5175 G>T variant in the MED13L gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.5175 G>T variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). In-silico splice models predict that c.5175 G>T may destroy a natural splice donor site in intron 22. However, in the absence of RNA/functional studies, the actual effect of the c.5175 G>T change in this individual is unknown. If c.5175 G>T does not alter splicing, it will result in the Q1725H missense change. The Q1725H variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret c.5175 G>T as a likely pathogenic variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.